Yuemao Shen Selected Research

Yuemao Shen Research Topics

Disease

20	Neoplasms (Cancer) 12/2023 - 09/2008
3	Inflammation (Inflammations) 12/2023 - 11/2003
3	Lung Neoplasms (Lung Cancer) 12/2023 - 04/2007
3	Prostatic Neoplasms (Prostate Cancer) 08/2015 - 01/2015
2	Neoplasm Metastasis (Metastasis) 12/2023 - 02/2023
2	Carcinogenesis 02/2023 - 11/2020
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2017 - 01/2014
2	Breast Neoplasms (Breast Cancer) 11/2014 - 01/2014
1	Triple Negative Breast Neoplasms 12/2023
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Dehydration (Water Stress) 01/2021
1	COVID-19 01/2021
1	Cytokine Release Syndrome 01/2021
1	Testicular Neoplasms (Testicular Cancer) 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Atherosclerosis 01/2015
1	Cholangiocarcinoma 06/2014
1	Pathologic Processes 11/2013
1	Osteoporosis 01/2013
1	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2012
1	Insulin Resistance 08/2012
1	Type 2 Diabetes Mellitus (MODY) 08/2012
1	Septic Shock (Toxic Shock Syndrome) 01/2012
1	Bacterial Infections (Bacterial Infection) 12/2011
1	Hypoglycemia (Reactive Hypoglycemia) 09/2008

Drug/Important Bio-Agent (IBA)

6	geldanamycinIBA 05/2023 - 10/2014
4	Proteins (Proteins, Gene)FDA Link 02/2023 - 06/2015
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2023 - 02/2023
3	Etoposide (VP 16)FDA LinkGeneric 12/2022 - 12/2019
2	Oncogene Proteins (Oncogene Protein)IBA 02/2023 - 04/2007
2	Teniposide (VM 26)FDA Link 01/2021 - 01/2020
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2016 - 01/2016
2	Phosphotransferases (Kinase)IBA 04/2016 - 10/2012
2	AndrogensIBA 08/2015 - 01/2015
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2015 - 06/2015
2	mycoepoxydieneIBA 01/2015 - 06/2014
1	ResveratrolIBA 12/2023
1	lapacholIBA 12/2023
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 12/2022
1	4'-demethylepipodophyllotoxinIBA 08/2021
1	TriazolesIBA 08/2021
1	ThiadiazolesIBA 08/2021
1	Podophyllotoxin (Condylox)FDA LinkGeneric 01/2021
1	polyporic acidIBA 01/2021
1	verucopeptinIBA 11/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2020
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 11/2020
1	Adenosine Triphosphatases (ATPase)IBA 11/2020
1	Topoisomerase InhibitorsIBA 12/2019
1	ferulic acid (sodium ferulate)IBA 12/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019
1	Protein Tyrosine PhosphatasesIBA 01/2019
1	TubulinIBA 01/2018
1	EnzymesIBA 05/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	LigandsIBA 01/2016
1	Cadherins (E-Cadherin)IBA 06/2015
1	Androgen Receptors (Androgen Receptor)IBA 06/2015
1	17- (6- (3,4- dimethoxycinnamamido)hexylamino)- 17- demethoxy- geldanamycinIBA 06/2015
1	SurvivinIBA 06/2015
1	Molecular Chaperones (Chaperone, Molecular)IBA 06/2015
1	Transcription Factors (Transcription Factor)IBA 06/2015
1	VimentinIBA 06/2015
1	oxidized low density lipoproteinIBA 01/2015
1	Apolipoproteins E (ApoE)IBA 01/2015
1	tanespimycin (17AAG)IBA 11/2014
1	trioctyl phosphine oxide (TOPO)IBA 10/2014
1	lissamine rhodamine B (sulforhodamine B)IBA 01/2014
1	Histone Deacetylase InhibitorsIBA 11/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2012
1	Insulin (Novolin)FDA Link 08/2012
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 08/2012
1	Blood Glucose (Blood Sugar)IBA 08/2012
1	Glucose (Dextrose)FDA LinkGeneric 08/2012
1	CytokinesIBA 01/2012
1	Biological Control AgentsIBA 12/2011
1	deacety mycoepoxydieneIBA 04/2011
1	Cytochromes c (Cytochrome c)IBA 09/2008
1	Indicators and Reagents (Reagents)IBA 09/2008
1	cytosporone BIBA 09/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2007
1	AlkaloidsIBA 11/2003

Therapy/Procedure

6	Therapeutics 01/2021 - 01/2015
3	Drug Therapy (Chemotherapy) 01/2021 - 12/2019
1	Castration 01/2015
1	Ovariectomy (Oophorectomy) 01/2013